Skp2 is a component of the E3 ubiquitin ligase, which promotes the ubiquitination-associated degradation of a cyclin-dependent kinase inhibitor p27, and increases NSCLC growth [37, 38]. Here, SKP2 is linked to non-small cell lung carcinoma.